Literature DB >> 11274402

Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling.

H Kaji1, L Canaff, J J Lebrun, D Goltzman, G N Hendy.   

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by endocrine tumors of parathyroids, pancreatic islets, and anterior pituitary. The MEN1 gene encodes a nuclear protein called menin. In MEN1 carriers inactivating mutations give rise to a truncated product consistent with menin acting as a tumor suppressor gene. However, the role of menin in tumorigenesis and its physiological functions are not known. Here, we show that menin inactivation by antisense RNA antagonizes transforming growth factor type beta-mediated cell growth inhibition. Menin interacts with Smad3, and antisense menin suppresses transforming growth factor type beta-induced and Smad3-induced transcriptional activity by inhibiting Smad3/4-DNA binding at specific transcriptional regulatory sites. These results implicate a mechanism of tumorigenesis by menin inactivation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274402      PMCID: PMC31139          DOI: 10.1073/pnas.061358098

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Cell cycle regulation of menin expression.

Authors:  H Kaji; L Canaff; D Goltzman; G N Hendy
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

2.  Smads bind directly to the Jun family of AP-1 transcription factors.

Authors:  N T Liberati; M B Datto; J P Frederick; X Shen; C Wong; E M Rougier-Chapman; X F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 3.  Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.

Authors:  S J Marx; S K Agarwal; M B Kester; C Heppner; Y S Kim; M C Skarulis; L A James; P K Goldsmith; S K Saggar; S Y Park; A M Spiegel; A L Burns; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; M R Emmert-Buck; S C Guru; P Manickam; J Crabtree; M R Erdos; F S Collins; S C Chandrasekharappa
Journal:  Recent Prog Horm Res       Date:  1999

4.  Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts.

Authors:  O Eickelberg; A Pansky; R Mussmann; M Bihl; M Tamm; P Hildebrand; A P Perruchoud; M Roth
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

5.  Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation.

Authors:  S L Stroschein; W Wang; K Luo
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

6.  Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.

Authors:  S L Stroschein; W Wang; S Zhou; Q Zhou; K Luo
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

7.  Smad2 and Smad4 gene mutations in hepatocellular carcinoma.

Authors:  M C Yakicier; M B Irmak; A Romano; M Kew; M Ozturk
Journal:  Oncogene       Date:  1999-08-26       Impact factor: 9.867

8.  Stable overexpression of MEN1 suppresses tumorigenicity of RAS.

Authors:  Y S Kim; A L Burns; P K Goldsmith; C Heppner; S Y Park; S C Chandrasekharappa; F S Collins; A M Spiegel; S J Marx
Journal:  Oncogene       Date:  1999-10-21       Impact factor: 9.867

9.  The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling.

Authors:  K Luo; S L Stroschein; W Wang; D Chen; E Martens; S Zhou; Q Zhou
Journal:  Genes Dev       Date:  1999-09-01       Impact factor: 11.361

10.  Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription.

Authors:  S K Agarwal; S C Guru; C Heppner; M R Erdos; R M Collins; S Y Park; S Saggar; S C Chandrasekharappa; F S Collins; A M Spiegel; S J Marx; A L Burns
Journal:  Cell       Date:  1999-01-08       Impact factor: 41.582

View more
  74 in total

1.  Pituitary adenomas in man and mouse: oncogenic potential of a truncated fibroblast growth factor receptor 4.

Authors:  Malcolm J Low
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Keeping neuroendocrine cells in check: roles for TGFbeta, Smads, and menin?

Authors:  G J Dockray
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 3.  Genetics of endocrine and metabolic disorders: parathyroid.

Authors:  R V Thakker
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

Review 4.  Genetics of pancreatic neuroendocrine tumors: implications for the clinic.

Authors:  Antonio Pea; Ralph H Hruban; Laura D Wood
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-09-28       Impact factor: 3.869

5.  Menin immunoreactivity in secretory granules of human pancreatic islet cells.

Authors:  Larisa V Debelenko; Sunita Agarwal; Qiang Du; Wusheng Yan; Heidi S Erickson; Mones Abu-Asab; Mark A Raffeld; Steven K Libutti; Stephen J Marx; Michael R Emmert-Buck
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014 Nov-Dec

6.  Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene.

Authors:  Junko Naito; Hiroshi Kaji; Hideaki Sowa; Riko Kitazawa; Sohei Kitazawa; Toshihiko Tsukada; Geoffrey N Hendy; Toshitsugu Sugimoto; Kazuo Chihara
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

7.  Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).

Authors:  Lucie Canaff; Jean-François Vanbellinghen; Hiroshi Kaji; David Goltzman; Geoffrey N Hendy
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

8.  Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1.

Authors:  Ping La; Yuqing Yang; Satyajit K Karnik; Albert C Silva; Robert W Schnepp; Seung K Kim; Xianxin Hua
Journal:  J Biol Chem       Date:  2007-08-31       Impact factor: 5.157

9.  Menin induces apoptosis in murine embryonic fibroblasts.

Authors:  Robert W Schnepp; Hua Mao; Stephen M Sykes; Wei-Xing Zong; Albert Silva; Ping La; Xianxin Hua
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

10.  Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.

Authors:  D Scarpelli; L D'Aloiso; F Arturi; A Scillitani; I Presta; M Bisceglia; C Cristofaro; D Russo; S Filetti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.